Bipolar Disorder: Clinical Trials

10 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown. 10 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Unknown 10
Phase 14Unknown 4
Phase 32Unknown 2

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEA vs. Placebo for Major Depression
Palmitoylethanolamide - Bipolar Depression, Major Depressive Disorder
Phase 2UnknownThe Israeli Medical Center for Alzheimer's1002022-12-212023-10-02
Brain Insulin Resistance in Mood Disorders
Humulin R, Diluent - Major Depressive Disorder, Bipolar Disorder
Phase 1 / Phase 2UnknownUniversity Health Network, Toronto1502021-10-062023-12-15
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis
Phase 1 / Phase 2UnknownAll Natural Medicine Clinic, LLC20002021-03-012021-05-26
Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression
Light - Bipolar Depression
Phase 1 / Phase 2UnknownAssistance Publique - Hôpitaux de Paris452019-09-302020-02-10
add-on Low Dose Memantine in Middle-to-old Aged Bipolar II Disorder Patients
Memantine or placebo - Bipolar II Disorder
Phase 2 / Phase 3UnknownNational Cheng-Kung University Hospital1202019-08-012021-03-09
Outcomes Mandate National Integration With Cannabis as Medicine
Cannabis, Medical, RYAH-Medtech Inhaler - Chronic Pain, Chronic Pain Syndrome
Phase 2UnknownOMNI Medical Services, LLC2000002018-12-012022-06-02
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
Vortioxetine, Placebo - Bipolar Disorder Depression
Phase 2UnknownSeoul National University Hospital1002018-08-082018-08-10
Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder
Allogenic FMT, Autologous FMT - Bipolar Depression
Phase 2 / Phase 3UnknownValerie Taylor352018-01-012022-05-04
Cognitive-Behavioral Rehabilitation for Bipolar Disorder
Cognitive Behavioral Rehabilitation, Treatment as Usual - Bipolar Disorder
Phase 1 / Phase 2UnknownUniversity of Sao Paulo602016-03-012022-05-26
Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
Memantine, Placebo - Bipolar Disorder
Phase 2UnknownUniversity of Sao Paulo442014-08-012019-10-03

Narrower conditions

Depression (3)  ·  Anxiety Disorders (2)  ·  Depressive Disorder, Major (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Stress Disorders, Post-Traumatic (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Ageusia (1)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Anemia, Sickle Cell (1)  ·  Anhedonia (1)  ·  Anosmia (1)  ·  Arthritis, Reactive (1)  ·  Autistic Disorder (1)  ·  Brain Injuries, Traumatic (1)

Broader conditions

Bipolar and Related Disorders (10)  ·  Mental Disorders (10)  ·  Mood Disorders (10)  ·  Behavior (3)  ·  Behavioral Symptoms (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Autoimmune Diseases (2)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Chronic Disease (2)  ·  Demyelinating Diseases (2)  ·  Depressive Disorder (2)  ·  Digestive System Diseases (2)

Interventions

Memantine (2)  ·  Cognitive Training (1)  ·  Insulin (1)  ·  Medical Marijuana (1)  ·  Therapeutics (1)  ·  Ultraviolet Therapy (1)  ·  Vortioxetine (1)  ·  palmidrol (1)

Sponsors

University of Sao Paulo (2)  ·  All Natural Medicine Clinic, LLC (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  National Cheng-Kung University Hospital (1)  ·  OMNI Medical Services, LLC (1)  ·  Seoul National University Hospital (1)  ·  The Israeli Medical Center for Alzheimer's (1)  ·  University Health Network, Toronto (1)  ·  Valerie Taylor (1)

Countries

Brazil (2)  ·  Canada (2)  ·  United States (2)  ·  France (1)  ·  Moldova (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Beny Lafer, Professor (1)  ·  Dr. Ryan O Lakin, MD JD (1)  ·  Ricardo A. Moreno, MD, PhD (1)  ·  Tzu-Yun Wang (1)  ·  Valerie Taylor, MD, PhD (1)  ·  Wanzhu Hou, CMD (1)  ·  Yong Min Ahn, MD, PHD (1)

Results publications

PMID 28351410, PMID 30466205, PMID 34261526, PMID 40608475, PMID 41785480